Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome

Antiplatelet therapy through inhibition of the adenosine diphosphate (ADP)/P2Y12 pathway is commonly used in the treatment of acute coronary syndrome (ACS). Although efficient in preventing platelet activation and thrombus formation, it increases the risk of bleeding complications. In patients with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Res Pract Thromb Haemost
Main Authors: Grosdidier, Charlotte, Blanz, Kelly D., Deharo, Pierre, Bernot, Denis, Poggi, Marjorie, Bastelica, Delphine, Wolf, Dennis, Duerschmied, Daniel, Grino, Michel, Cuisset, Thomas, Alessi, Marie‐Christine, Canault, Matthias
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles: Thrombosis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6781928/
https://ncbi.nlm.nih.gov/pubmed/31624788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12244
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares